Role of tumor-associated macrophage in malignant tumors: Should the location of the infiltrated macrophages be taken into account during evaluation?

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4269-4275

  Ohno, Satoshi ^a,b   Inagawa, Hiroyuki ^c   Soma, Gen Ichiro ^c   Nagasue, Naofumi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Cytotoxicity; Histopathology; Prognosis; Stroma formation; Tumor associated macrophage (TAM)

Indexed keywords

ANGIOGENESIS; CELL INFILTRATION; CONFERENCE PAPER; CYTOTOXICITY; DISEASE ASSOCIATION; EVALUATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; STROMA; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; MACROPHAGES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0036875368     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Svennevig JL and Svaar H: Content and distribution of macrophages and lymphocytes in solid malignant human tumours. Int J Cancer 24: 754-758, 1979.
2. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M and Mantovani A: Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210-212, 1983.
3. Mantovani A: Biology of disease: tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71: 5-16, 1994.
4. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
5. Ohno S, Tachibana M, Fujii T, Ueda S, Kubota H and Nagasue N: Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma. Int J Cancer 97: 770-774, 2002.
6. Eymard JC, Lopez M, Cattan A, Bouche O, Adjizian JC and Bernard J: Phase I/II trial of autologous activated macrophages in advanced colorectal cancer. Eur J Cancer 32A: 1905-1911, 1996.
7. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T and Blankenstein T: Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc Natl Acad Sci USA 90: 2774-2778, 1993.
8. Bucana C, Hoyer LC, Hobbs B, Breesman S, McDaniel M and Hanna MG Jr: Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells. Cancer Res 36: 4444-4458, 1976.
9. Fidler IJ, Jessup JM, Fogler WE, Staerkel R and Mazumder A: Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma. Cancer Res 46: 994-998, 1986.
10. Bernasconi S, Peri G, Sironi M and Mantovani A: Involvement of leukocyte (β2) integrins (CD18/CD11) in human monocyte tumoricidal activity. Int J Cancer 49: 267-273, 1991.
11. Bonta IL and Ben-Efraim S: Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol 54: 613-626, 1993.
12. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T and Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1992.
13. Schmidt HHHW and Walter U: NO at work. Cell 78: 919-925, 1994.
14. MacMicking J, Xie QW and Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350, 1997.
15. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995.
16. Naama HA, Mack VE, Smyth GP, Stapleton PP and Daly JM: Macrophage effector mechanisms in melanoma in an experimental study. Arch Surg 136: 804-809, 2001.
17. Elgert KD, Alleva DG and Mullins DW: Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64: 275-290, 1998.
18. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O and Langenbach R: Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduced intestinal tumorigenesis in Min mice. Cancer Res 60: 4705-4708, 2000.
19. Harris SG, Padilla J, Koumas L, Ray D and Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150, 2002.
20. Alleva DG, Burger CJ and Elgert KD: Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production; role of tumor-derived IL-10, TGF-β, and prostaglandin E2. J Immunol 153: 1674-1686, 1994.
21. Seljelid R: Tumor immunology: alternative perspectives. Scand J Immunol 46: 437-444, 1997.
22. Ruiter D, Bogenrieder T, Elder D and Herlyn M: Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol 3: 35-43, 2002.
23. Ohtani H: Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathol Int 48: 1-9, 1998.
24. Cox G and O'Byrne KJ: Matrix metalloproteinases and cancer. Anticancer Res 21: 4207-4220, 2001.
25. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K: Localization of messenger RNA for 72-kDa and 92-kDa-type IV collagenases in human skin cancer by in situ hybridization. Cancer Res 52: 1336-1341, 1992.
26. Gray ST, Wilkins RJ and Yun K: Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 141: 389-396, 1992.
27. Gray ST, Yun K, Motoori T and Kuys YM: Interstitial collagenase gene expression in colonic neoplasia. Am J Pathol 143: 663-671, 1993.
28. Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490, 2000.
29. Fodak VA, Bratton DL, Konowal A, Freed PW, Westcott JY and Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibits proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 101: 890-898, 1998.
30. McDonald PP, Fodak VA, Bratton D and Henson PM: Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells. J Immunol 163: 6164-6172, 1999.
31. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
32. Polverini PJ and Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635-642, 1984.
33. Stenzinger W, Brggen J, Macher E and Sorg C: Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma. Eur J Cancer Clin Oncol 19: 649-656, 1983
34. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaji R and Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55: 410-422, 1994.
35. Crowther M, Brown NJ, Bishop ET and Lewis CE: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70: 478-490, 2001.
36. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M and Lewis CE: Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 196: 204-212, 2002.
37. Harmey JH, Dimitriadis E, Kay E, Redmond HP and Bouchier-Hayes D: Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol 5: 271-278, 1998.
38. Scannell G, Waxman K, Kaml GJ, Ioli G, Gatanaga T, Yamamoto R and Granger GA: Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res 54: 281-285, 1993.
39. Leek RD, Lewis CE and Harris AL: The role of macrophages in tumour angiogensis. In: Tumour Angiogenesis, Bicknell R, Lewis CE and Ferrara N (eds), Oxford University Press: Oxford, 1997
40. Lewis CE: Regulation of tumour angiogenesis by macrophages: role of hypoxia and angiogenic factor production. Clin Exp Met 15: 74, 1996.
41. Underwood JCE: Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer 30: 538-548, 1974.
42. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H and Ohtani H: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494, 1998.
43. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A and Thompson TC: Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60: 5857-5861, 2000.
44. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast cancer. Cancer Res 56: 4625-4629, 1996.
45. Dhar DK, Kubota H, Kotoh T, Tabara H, Watanabe R, Tachibana M, Kohno H and Nagasue N: Tumor vascularity predicts recurrence in differentiated thyroid carcinoma. Am J Surg 176: 442-447, 1998.
46. Takanami I, Takeuchi K and Kodaira S: Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57: 138-142, 1999.
47. Mäkitie T, Summanen P, Tarkkanen A and Kivelä T: Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Opbtbalmol Vis Sci 42: 1414-1421, 2001.
48. Salvesen HB and Akslen LA: Significance of tumor-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84: 539-543, 1999.
49. Leek RD: The prognostic role of ahngiogenesis in breast cancer. Anticancer Res 21: 4325-4331, 2001.
50. Kakolyris S, Giatromanolaki A, Koukourakis M, Kaldamanis L, Kouroussis C, Bozionelou V, Georgoulias V, Gatter KC and Harris AZ: Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39. Anticancer Res 21: 4311-4316, 2001.
51. Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M and Kudo T: Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res 20: 4853-4856, 2000.
52. Leek RD, Landers RJ, Harris AL and Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991-995, 1999.
53. Migita T, Sato E, Saito K, Mizoi T, Shiiba K, Matsuno S, Nagura H and Ohtani H: Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma. Int J Cancer 84: 74-79, 1999.